Understanding the Different Types of Lymphoma 🩺

Lymphoma is a cancer of the lymphatic system—the network of vessels and organs that help your body fight infection. If you or someone you care about has received a lymphoma diagnosis, understanding the main types is an important first step. The type matters because it shapes treatment options, how the disease typically progresses, and what doctors will monitor.

There are two broad categories of lymphoma, and dozens of subtypes within them. This article explains the landscape so you can ask informed questions with your healthcare team.

The Two Main Categories: Hodgkin and Non-Hodgkin

Hodgkin lymphoma and non-Hodgkin lymphoma (NHL) are distinguished by how the cancer cells look under a microscope. Specifically, doctors look for the presence of Reed-Sternberg cells—large, abnormal cells found in Hodgkin lymphoma but not in other types.

This distinction matters because the two categories behave differently, respond to different treatments, and follow different patterns of spread. They also affect different age groups, though both can occur at any age.

Hodgkin Lymphoma

Hodgkin lymphoma accounts for roughly 10% of all lymphomas. It tends to spread in an orderly, predictable way from one lymph node group to nearby groups, which actually helps doctors stage and treat it.

Key characteristics:

• Often presents with enlarged lymph nodes in the neck, chest, or underarm
• May cause unexplained fevers, night sweats, or weight loss
• More common in people in their 20s and those over 55
• Generally has clearer treatment pathways

Non-Hodgkin Lymphoma: A Broader Category

Non-Hodgkin lymphoma is actually a diverse group of more than 60 subtypes, divided broadly by how fast the cancer cells grow.

Indolent (Slow-Growing) Lymphomas

Indolent lymphomas grow slowly and may not require immediate treatment. Common types include:

• Follicular lymphoma — the most common indolent type
• Small lymphocytic lymphoma (SLL) — sometimes called chronic lymphocytic leukemia when it involves the blood
• Marginal zone lymphoma — includes nodal, splenic, and extranodal varieties
• Primary cutaneous lymphomas — develop in the skin itself

These often respond well to initial treatment but may eventually become resistant or transform into a more aggressive type.

Aggressive (Fast-Growing) Lymphomas

Aggressive lymphomas require prompt treatment but may respond more completely to therapy. The most common:

• Diffuse large B-cell lymphoma (DLBCL) — the most frequent aggressive type
• Burkitt lymphoma — grows very rapidly but responds well to intense treatment
• Lymphoblastic lymphoma — more common in children and young adults
• Primary mediastinal B-cell lymphoma — starts in the chest

The speed of growth does not always predict treatment success. Some fast-growing lymphomas respond very well to chemotherapy, while some slow-growing types are trickier to manage long-term.

What Influences the Type and Subtype?

Several factors affect which type of lymphoma a person develops:

Cell origin. Most lymphomas begin in B cells or T cells, two types of white blood cells that fight infection. B-cell lymphomas are far more common than T-cell lymphomas.

Location. Lymphoma can start in lymph nodes, the spleen, bone marrow, the liver, the digestive tract, or the skin. Where it starts influences classification and treatment.

Age and immune status. Certain types are more common in older adults. People with weakened immune systems (from HIV, organ transplant, or certain medications) face higher risk for specific subtypes.

Genetic and molecular features. Modern pathology examines not just how cells look but their genetic mutations and protein markers. This helps doctors predict behavior and tailor treatment.

How Doctors Determine Your Type 📋

Diagnosis requires a biopsy—removing a small sample of affected tissue for examination under a microscope. Doctors may also order blood tests, imaging scans, and specialized genetic testing to classify the lymphoma precisely and determine its stage.

This process takes time. Getting a clear diagnosis before starting treatment is worth the wait because it directly affects your treatment plan.

Why the Type Matters for Your Care

The specific type shapes:

• Treatment approach — some respond better to chemotherapy, immunotherapy, or targeted drugs
• Monitoring schedule — indolent types may be watched before treatment; aggressive types typically need prompt intervention
• Prognosis and outcomes — different subtypes have different patterns of response and long-term outlook
• Side effect profiles — different drugs carry different risks

Next Steps: Questions to Ask Your Team

Once you know your lymphoma type and subtype, work with your oncologist and healthcare team to understand:

• What your specific subtype means for treatment options available to you
• How stage and other factors affect the plan
• What monitoring and follow-up will look like
• Where to find reliable information specific to your diagnosis

Understanding the types of lymphoma is foundational, but your individual situation—your age, overall health, the stage at diagnosis, and how your specific cells respond to treatment—will shape what happens next. Your care team has the expertise to assess those factors and recommend the best path forward.